PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Klancic, T. ; Woodward, L.* ; Hofmann, S.M. ; Fisher, E.A.*

High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties.

Mol. Metab. 5, 321-327 (2016)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Background: High density lipoproteins (HDLs) are thought to be atheroprotective and to reduce the risk of cardiovascular disease (CVD). Besides their antioxidant, antithrombotic, anti-inflammatory, anti-apoptotic properties in the vasculature, HDLs also improve glucose metabolism in skeletal muscle. Scope of the review: Herein, we review the functional role of HDLs to improve metabolic disorders, especially those involving insulin resistance and to induce regression of CVD with a particular focus on current pharmacological treatment options as well as lifestyle interventions, particularly exercise. Major conclusions: Functional properties of HDLs continue to be considered important mediators to reverse metabolic dysfunction and to regress atherosclerotic cardiovascular disease. Lifestyle changes are often recommended to reduce the risk of CVD, with exercise being one of the most important of these. Understanding how exercise improves HDL function will likely lead to new approaches to battle the expanding burden of obesity and the metabolic syndrome.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.363
1.419
13
14
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Atherosclerotic Plaque Regression ; Glucose Homeostasis ; Hdl Function ; High Density Lipoprotein (hdl) ; Metabolic Disease ; Physical Activity; Type-2 Diabetes-mellitus; Apolipoprotein-a-i; Coronary-artery-disease; Cholesterol Efflux Capacity; Randomized Controlled-trial; Extended-release Niacin; Monocyte-derived Cells; E-deficient Mice; Atherosclerosis Regression; Glucose-metabolism
Language english
Publication Year 2016
HGF-reported in Year 2016
ISSN (print) / ISBN 2212-8778
e-ISSN 2212-8778
Journal Molecular Metabolism
Quellenangaben Volume: 5, Issue: 5, Pages: 321-327 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Regeneration Research (IDR)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502390-001
PubMed ID 27110484
DOI 10.1016/j.molmet.2016.03.001
WOS ID WOS:000374301000002
Scopus ID 84962432704
Erfassungsdatum 2016-05-10
[➜Report correction]